CRSP
#1345
CRISPR Therapeutics AG - Common Shares
50.5 5 USD
-0.05%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-5.25%
Monthly Change
+1.53%
6 month change
-6.39%
Year Change
-9.47%
Previous Close
53.3 5
Open
50.8 0
Low
50.5 2
High
51.1 4
Volume
701
Financials
- Market Capitalization 4.88 B
- Employee 393
- Founded 2013
- CEO Samarth Kulkarni
- Website www.crisprtx.com
- Headquarter Switzerland
- FIGI UNKNOWN
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-8.11
Price to sales ratio
1 343.5
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1296 |  DNTH Dianthus Therapeutics, Inc. - Common Stock | 96.88 USD | -0.74% | +4.07% | +25.10% | +378.18% | 5.30 B USD | ||
| 1308 |  TVTX Travere Therapeutics, Inc. - Common Stock | 56.28 USD | -0.55% | -2.78% | +14.62% | +95.62% | 5.23 B USD | ||
| 1355 |  CELC Celcuity Inc. - Common Stock | 100.81 USD | -6.29% | -5.47% | +12.70% | +610.93% | 4.92 B USD | ||
| 1370 |  DFTX Definium Therapeutics, Inc. - Common Shares | 43.57 USD | -7.44% | -0.68% | +75.90% | +188.35% | 4.75 B USD |
Frequently asked questions about CRISPR Therapeutics AG - Common Shares
What is the CRISPR Therapeutics AG - Common Shares stock price today?
The current price of CRISPR Therapeutics AG - Common Shares (CRSP) is 50.55. Over the past 24 hours, the stock has changed by -5.25%. Follow the CRSP chart for real-time price dynamics.
What is the stock ticker of CRISPR Therapeutics AG - Common Shares?
CRISPR Therapeutics AG - Common Shares trades under the ticker CRSP. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is CRISPR Therapeutics AG - Common Shares stock going up?
CRSP has changed by -18.07% over the last week, +1.53% over the last month, and -9.47% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was CRISPR Therapeutics AG - Common Shares net income for the last quarter?
CRISPR Therapeutics AG - Common Shares reported net income of -122.93 M for the last quarter. The previous quarter showed -130.61 M, which means net income changed by +5.88%.
How many employees does CRISPR Therapeutics AG - Common Shares have?
As of the latest available data, CRISPR Therapeutics AG - Common Shares has 393 employees. Workforce size can provide additional context about the company's scale and operations.
What is CRISPR Therapeutics AG - Common Shares EBITDA?
CRISPR Therapeutics AG - Common Shares EBITDA is -125.93 M, and its EBITDA margin is -8 637.11%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy CRISPR Therapeutics AG - Common Shares stock?
You can buy CRISPR Therapeutics AG - Common Shares (CRSP) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in CRISPR Therapeutics AG - Common Shares stock?
Investing in CRISPR Therapeutics AG - Common Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CRSP chart and related analysis on metatrader.com as part of your research.